Vireo Growth (VREOF) Operating Leases (2020 - 2026)
Vireo Growth (VREOF) reported Operating Leases of $174.4 million for Q1 2026, up 961.0% on a YoY basis from $16.4 million in Q1 2025, and up 19.21% sequentially from $146.3 million in Q4 2025.
Vireo Growth (VREOF) Operating Leases (2020 - 2026) Analysis & Trends
Vireo Growth (VREOF) has 7 years of Operating Leases data on file, last reported at $174.4 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Leases rose 961.0% year-over-year to $174.4 million; the trailing twelve-month figure through Mar 2026 stood at $174.4 million (up 961.0% YoY), and the FY2025 full-year result was $146.3 million, up 786.97% from the prior year.
- Operating Leases advanced to $174.4 million in Q1 2026, from $146.3 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $174.4 million in Q1 2026 to a low of $9.7 million in Q2 2023.
- A 5-year average of $50.5 million and a median of $19.6 million in 2024 frame the typical range for Operating Leases.
- Across the five-year window, Operating Leases slumped 88.01% in 2023 and soared 961.0% in 2026, its largest moves.
- Tracing VREOF's Operating Leases over 5 years: stood at $79.8 million in 2022, then tumbled by 86.78% to $10.5 million in 2023, then surged by 56.44% to $16.5 million in 2024, then surged by 786.97% to $146.3 million in 2025, then advanced by 19.21% to $174.4 million in 2026.
- Business Quant data shows VREOF's Operating Leases at $174.4 million in Q1 2026, $146.3 million in Q4 2025, and $41.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 174.40 Mn |
| Dec 31, 2025 | 146.30 Mn |
| Sep 30, 2025 | 41.77 Mn |
| Jun 30, 2025 | 43.19 Mn |
| Mar 31, 2025 | 16.44 Mn |
| Dec 31, 2024 | 16.49 Mn |
| Sep 30, 2024 | 19.05 Mn |
| Jun 30, 2024 | 19.47 Mn |
| Mar 31, 2024 | 19.64 Mn |
| Dec 31, 2023 | 10.54 Mn |
| Sep 30, 2023 | 9.70 Mn |
| Jun 30, 2023 | 9.67 Mn |
| Mar 31, 2023 | 10.37 Mn |
| Dec 31, 2022 | 79.76 Mn |
| Sep 30, 2022 | 80.88 Mn |
| Jun 30, 2022 | 80.45 Mn |
| Mar 31, 2022 | 79.92 Mn |
| Dec 31, 2021 | 80.23 Mn |
| Sep 30, 2021 | 78.61 Mn |
| Jun 30, 2021 | 21.79 Mn |